Characterization of an overlapping CD8+ and CD4+ T-cell epitope on rubella capsid protein

Virology

Volumn 235, Issue 2, 1997, Pages 286-292

  Ou, Dawei ^a   Mitchell, Leslie Ann ^a   Décarie, Diane ^a   Gillam, Shirley ^a   Tingle, Aubrey J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; RUBELLA VACCINE; SYNTHETIC PEPTIDE;

ARTICLE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RUBELLA; RUBELLA VIRUS; T LYMPHOCYTE;

MIRIDAE; RUBELLA VIRUS; VACCINIA;

EID: 0030824663     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8704     Document Type: Article

References (47)

1. B. AIDS Res. Hum. Retroviruses. 10:1994;19-25.
2. Brodsky F. M., Parham P. Monomorphic anti-HLA-A, B, C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J. Immunol. 128:1982;129-135.
3. ++. J. Immunol. 148:1992;894-899.
4. Celis E., Tsai V., Crimi C., DeMars R., Wentworth P. A., Chesnut R. W., Grey H. M., Sette A., Serra H. M. Induction of anti-tumour cytotoxic T lymphocytes in normal human using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA. 91:1994;2105-2109.
5. Chantler J. K., Ford D. K., Tingle A. J. Persistent rubella infection and rubella-associated arthritis. Lancet. i:1982;1323-1325.
6. Chaye H. H., Chong P., Tripet B., Brush B., Gillam B. Localization of the virus neutralizing and hemagglutinin epitopes of E1 glycoprotein of rubella virus. Virology. 189:1992a;483-492.
7. Chaye H. H., Mauracher C. A., Tingle A. J., Gillam S. Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C. J. Clin. Microbiol. 30:1992b;2323-2329.
8. Clarke D. M., Loo T. W., Hui I., Chong P., Gillam S. Nucleotide sequence and in vitro expression of rubella virus 24S subgenomic messenger RNA encoding the structural proteins E1, E2 and C. Nucleic Acids Res. 15:1987;3041-3057.
9. +. J. Immunol. 147:1991;4069-4073.
10. +. J. Immunol. 157:1996;787-797.
11. Fraser J. R. E., Cunningham A. L., Hayes K., Leach R., Lunt R. Rubella arthritis in adults. Isolation of virus, cytology and other aspects of synovial reaction. Clin. Exp. Rheumatol. 1:1983;287-293.
12. Giles R. C., Nunez G., Hurley C. K., Nunez-Roldan A., Winchester R., Stastny P., Capra J. D. Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity. J. Exp. Med. 157:1983;1461-1470.
13. Hobman T. C., Lundstrom M., Gillam S. Processing and intracellular transport of rubella virus structural proteins in COS cells. Virology. 178:1990;122-133.
14. Kubo R. T., Sette A., Grey H. M., Appella E., Sakaguchi K., Zhu N-Z., Arnott D., Sherman N., Shabanowitz J., Michel H., Bodnar W. M., Davis T. A., Hunt D. F. Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol. 152:1994;3913-3924.
15. Lampson L. A., Levy R. Two population of Ia-like molecules on a human B cell line. J. Immunol. 125:1980;293-299.
16. Lovett A. E., Hahn C. S., Rice C. M., Frey T. K., Wolinsky J. S. Rubella virus-specific cytotoxic T-lymphocyte responses: Identification of the capsid as a target of major histocompatibility complex class I-restricted lysis and definition of two epitopes. J. Virol. 67:1993;5849-5858.
17. Lozzi L., Rustici M., Corti M., Cusi M. G., Valensin P. E., Bracci L., Santucci A., Soldani P., Spreafico A., Neri P. Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis. Arch. Virol. 110:1990;271-276.
18. Mackett M., Smith G. L., Moss B. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol. 49:1984;857-864.
19. Marttila J., Ilonen J., Lehtinen M., Parkkonen P., Salmi A. Definition of three minimal T helper cell epitopes of rubella virus E1 glycoprotein. Clin. Exp. Immunol. 104:1996;394-397.
20. ++. J. Virol. 68:1994;8056-8063.
21. McCarthy M., Lovett A., Kerman R. H., Overstreet A., Wolinsky J. S. Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides. J. Virol. 67:1993;673-681.
22. McMichael A. J., Gotch F. M., Noble G. R., Beare P. A. S. Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 309:1983;13-17.
23. Milich D. R. Synthetic T and B cell recognition sites: Implications for vaccine development. Adv. Immunol. 45:1988;195-281.
24. Milich D. R., Hughes J. L., McLachlan A., Thornton G. B., Moriarty A. Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope. Proc. Natl. Acad. Sci. USA. 85:1988;1610-1614.
25. Mitchell L. A., Zhang T., Ho M., Décarie D., Tingle A. J., Zrein M., Lacroix M. Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay. J. Clin. Microbiol. 30:1992;1841-1847.
26. Mitchell L. A., Décarie D., Tingle A. J., Zrein M., Lacroix M. Identification of immunoreactive regions of rubella virus E1 and E2 envelope proteins by using synthetic peptides. Virus Res. 29:1993;33-57.
27. Oker-Blom C., Kalkkinen N., Kaariainen L., Pettersson R. F. Rubella virus contains one capsid protein and three envelope glycoprotein, E1, E2a and E2b. J. Virol. 46:1983;964-973.
28. Oldstone M. B. A., Tishon A., Geckeler R., Lewicki H., Whitton J. L. A common antiviral cytotoxic T-lymphocyte epitope for diverse major histocompatibility complex haplotypes: Implications for vaccination. Proc. Natl. Acad. Sci. USA. 89:1992;2752-2755.
29. Ou D., Chong P., Tripet B., Gillam S. Analysis of T- and B-cell epitopes of capsid protein of rubella virus by using synthetic peptide. J. Virol. 66:1992a;1674-1681.
30. +. Virology. 191:1992b;680-686.
31. +. J. Virol. 66:1992c;6788-6793.
32. Ou D., Chong P., Tingle A. J., Gillam S. Mapping T-cell epitope of rubella virus structural proteins E1, E2 and C recognized by T-cell lines and clones derived from infected and immunized populations. J. Med. Virol. 40:1993;175-183.
33. Ou D., Mitchell L. A., Ho M., Décarie D., Tingle A. J., Nepom G. T., Lacroix M., Zrein M. Analysis of overlapping T- and B-cell antigenic sites on rubella virus E1 envelope protein: Influence of HLA-DR4 polymorphism on T-cell clonal recognition. Hum. Immunol. 39:1994;177-187.
34. Ou D., Mitchell L. A., Domeier M. E., Tsang A. O. W., Décarie D., Tingle A. J., Nepom G. T., Lacroix M., Zrein M. Characterization of the HLA restrictive elements of a rubella virus-specific cytotoxic T-cell clone: Influence of HLA-DR4β chain residue 74 polymorphism on antigenic peptide-T cell interaction. Int. Immunol. 8:1996;1577-1586.
35. Perfins F. T. Licensed vaccines. Rev. Infect. Dis. 7:1985;573-576.
36. Quinnan G. V., Kirmeni N., Rook A. H., Manishevitz J. V., Jackson L., Moreschi G., Santos G. W., Saral R., Burns W. H. Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non T-lymphocyte cytotoxic response correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N. Engl. J. Med. 307:1982;6-13.
37. +. Immunol. Today. 14:1993;345-348.
38. Rivoltini L., Loftus D. J., Barracchini K., Arienti F., Mazzocchi A., Biddison W. E., Salgaller M. L., Appella E., Parmiani G., Marincola F. M. Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes: Implications for peptide-based immunotherapy. J. Immunol. 156:1996;3882-3891.
39. Robbins P. A., Garboczi D. N., Strominger J. L. HLA-A*0201 complexes with two 10-mer peptides differing at the P2 anchor residue have distinct refolding kinetics. J. Immunol. 154:1995;703-709.
40. Rouse B. T., Norley S., Martin S. Antiviral cytotoxic T lymphocyte induction and vaccination. Rev. Infect. Dis. 10:1988;16-33.
41. Sandra W. B., Stetler H. C., Preblud S. R., Williams N. N., Orenstein W. A., Bart K. J., Hinman A. R., Herrmann K. L. Fetal risk associated with rubella vaccine: An update. Rev. Infect. Dis. 7:1985;S95-S102.
42. Stuhler G., Walden P. Collaboration of helper and cytotoxic T lymphocytes. Eur. J. Immunol. 23:1993;2279-2286.
43. Terry G. M., Ho-Terry L., Londesborough P., Rees K. R. Localization of rubella E1 epitopes. Arch. Virol. 98:1988;189-197.
44. Tingle A. J., Mitchell L. A., Grace M., Middleton P., Mathias R., MacWilliam L. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women. Lancet. 349:1997;1277-1281.
45. +. J. Exp. Med. 183:1996;1965-1971.
46. Wolinsky J. S., McCarthy M., Allen-Canady O., Moore W. T., Jin R., Cao S-N., Lovett A., Simmons D. Monoclonal antibody-defined epitope map of expressed rubella virus protein domains. J. Virol. 65:1991;3986-3994.
47. Wolinsky J. S., Sukholutsky E., Moore W. T., Lovett A., McCarthy M., Adame B. An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain. J. Virol. 67:1993;961-968.